Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C11H11BrN2S |
| Molecular Weight | 283.187 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
BrC1=CC=C(C=C1)[C@H]2CN3CCSC3=N2
InChI
InChIKey=HTHGAIADRJRJOY-SNVBAGLBSA-N
InChI=1S/C11H11BrN2S/c12-9-3-1-8(2-4-9)10-7-14-5-6-15-11(14)13-10/h1-4,10H,5-7H2/t10-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/171243Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/455643
Sources: https://www.ncbi.nlm.nih.gov/pubmed/171243
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/455643
(-)-p-Bromotetramisole is an inhibitor of non-specific alkaline phosphatase. L-p-Bromotetramisole shows no inhibition of specific phosphatase activity, and the D-enantiomer shows no inhibitory effects against either phosphatase. L-p-Bromotetramisole is used as a tool inhibitor in studies of tissue distribution of alkaline phosphatases.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL5979 Sources: https://www.ncbi.nlm.nih.gov/pubmed/557560 |
1.8 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Use of specific inhibitors to disciminate alkaline phosphatase isoenzymes originating from human liver, placenta and intestine: absence of meconial alkaline phosphatase in maternal serum. | 1979-07 |
|
| Tetramisole analogues as inhibitors of alkaline phosphatase, an enzyme involved in the resistance of neoplastic cells to 6-thiopurines. | 1977-04 |
|
| The inhibition of alkaline phosphatase by L-p-bromotetramisole. | 1975-08-28 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/557560
(-)-p-Bromotetramisole inhibited alkaline phosphatase from the murine ascitic neoplasm Sarcoma 180/TG with IC50 of 1.8 uM.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OEN33FEM7H
Created by
admin on Mon Mar 31 23:20:50 GMT 2025 , Edited by admin on Mon Mar 31 23:20:50 GMT 2025
|
PRIMARY | |||
|
56943-06-7
Created by
admin on Mon Mar 31 23:20:50 GMT 2025 , Edited by admin on Mon Mar 31 23:20:50 GMT 2025
|
PRIMARY | |||
|
DTXSID10350780
Created by
admin on Mon Mar 31 23:20:50 GMT 2025 , Edited by admin on Mon Mar 31 23:20:50 GMT 2025
|
PRIMARY | |||
|
688042
Created by
admin on Mon Mar 31 23:20:50 GMT 2025 , Edited by admin on Mon Mar 31 23:20:50 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD